Searchable abstracts of presentations at key conferences in endocrinology

ea0063p904 | Diabetes, Obesity and Metabolism 3 | ECE2019

Case report: Bullous pemphigoid in a patient with type 2 Diabetes on treatment with linagliptin

Gonzalez Lazaro Paloma , Contreras Pascual Cristina , del Val Zaballos Florentino , Silva Fernandez Julia , Torres Arroyo Belvis , Javier Gomez Alfonso Francisco , Garcia Manzanares Vazquez de Agredos Alvaro , Gomez Garcia Ines

Introduction: The association of bullous pemphigoid (BP) with the use of dipeptidyl-peptidase 4 (DPP-4) inhibitors among patients with diabetes has recently emerged. The risk of developing BP during treatment with new DPP-4 inhibitor agents like linagliptin is yet to be established. The clinical features and the prognostic outcomes of patients with DPP-4 inhibitor-associated BP are yet to be established.Objective: To report a case of BP on a patient with...

ea0041ep46 | Adrenal cortex (to include Cushing's) | ECE2016

Ipilimumab immunotheraphy for advanced melanoma induced autoimmune adrenalitis

Silva-Fernandez Julia , Morales-Chamorro Rafael , Gomez-Alfonso Francisco Javier , Val-Zaballos Florentino Del , Garcia-Manzanares-Vazquez de Agredos Alvaro , Lopez-Iglesias Maria , Garcia-Ruiz Rafael , Gomez-Garcia Ines

Introduction: Ipilimumab is a monoclonal antibody against the inhibitory CTLA-4 receptor expressed on T cells. It provokes an upregulation of the immune system. It is known to cause neuroendocrine disorders, such as hypophysitis, hyppothyroidism/thyroiditis and adrenal insufficiency. Althought it is stipulated that thyroid.stimulating hormone (TSH) levels should be evaluated before administration of each dose of ipilimumab as a screen for thyroid diyfunction, there is no reque...

ea0070aep726 | Pituitary and Neuroendocrinology | ECE2020

Efficacy and safety of urea in syndrome of inappropriate secretion of antidiuretic hormone on a secondary hospital

Moreno Tirado Antonio , González Lázaro Paloma , Contreras Pascual Cristina , Montalban Mendez Cristina , Garcia Manzanares Vazquez De Agredos Alvaro , Del Val Zaballos Florentino , Silva Fernandez Julia , Javier Gomez Alfonso Francisco , Rosa Gomez Garcia Ines , Lomas Meneses Amparo

Introduction: The most common cause of hyponatraemia is the syndrome of inappropriate antidiuretic hormone (SIADH). The diagnosis typically requires hyponatraemia in the setting of reduced serum osmolality, inappropriately concentrated urine with normal sodium excretion levels, and the absence of interfering medications, hypothyroidism and adrenal insufficiency. Unless hypertonic saline is indicated for acute onset profound hyponatraemia and/or with severe symptoms, the mainst...

ea0056p799 | Pituitary - Clinical | ECE2018

Severe hypernatremia resulting in a locked-in syndrome

Silva-Fernandez Julia , Garcia-Ruiz Rafael , Javier Gomez-Alfonso Francisco , Del Val-Zaballos Florentino , Torres-Arroyo Belvis , Gonzalez-Lazaro Paloma , Contreras-Pascual Cristina , Garcia-Manzanares Vazquez de Agredos Alvaro , Gomez-Garcia Ines

Introduction: Osmotic demyelination syndrome (ODS) is a well described, potentially devastating consequence of rapid alterations in plasma osmolality, classically occurring secondary to the excessively rapid correction of chronic hyponatraemia. We describe a case of diabetes insipidus (DI) resulting in a Locked-in syndrome (LIS) caused by a rapidly developing severe hypernatremia.Case report: A 43-year-old woman was admitted to the Internal Medicine ward...